Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Anesthesiology
    • Cardioversion as first...

    Cardioversion as first treatment strategy for AFib results in shorter ED length of stay: Clinical trial

    Written by Hina Zahid Published On 2019-09-13T20:20:34+05:30  |  Updated On 13 Sept 2019 8:20 PM IST
    Cardioversion as first treatment strategy for AFib results in shorter ED length of stay: Clinical trial

    Researchers at Department of Emergency Medicine at St. Paul's Hospital and the University of British Columbia, Vancouver have found in a multicenter randomized controlled clinical trial that cardioversion or electrical-first strategy results in a significantly shorter emergency department (ED) length of stay in the treatment of acute atrial fibrillation. As such both chemical-first and electrical-first approaches are effective strategies for acute atrial fibrillation. The study findings are published in Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).


    The study may assist clinicians by demonstrating that the electrical-first strategy may restore sinus rhythm more quickly. The results should encourage clinicians to initially consider an electrical-first approach for such patients.


    The trial results showed that in uncomplicated ED atrial fibrillation patients of less than 48 hours, a significantly greater proportion of ED patients were discharged from the ED within four hours when managed with an electrical-first cardioversion strategy, compared to a chemical? first cardioversion strategy. In addition, the median LOS was shorter by 1.2 hours for the electrical? first group.


    The findings add to the literature by comparing two accepted treatments, measuring important outcomes--including patient-reported results--and demonstrating that these patients, irrespective of initial management strategy, are safe; have minimal discomfort after their ED visit; have an acceptable QoL at 3 and 30 days.


    Commenting on the study is Editor-in-Chief of the Canadian Journal of Emergency Medicine, Ian G. Stiell, MD, MSc, a distinguished professor and senior scientist in the Department of Emergency Medicine, Ottawa Hospital Research Institute, University of Ottawa:


    "This study confirms that both chemical-first and electrical-first approaches are effective strategies for acute atrial fibrillation. Immediate rhythm control by ED physicians allows rapid discharge of patients and early return to normal activities. Whether drug first or shock first should be determined by patient or physician preference."

    Academic Emergency MedicineAFibatrial fibrillationCardioversioncardioversion strategyFrank X ScheuermeyerIan G Stiellrhythm controlSt Paul's HospitalstrokeUniversity of British ColumbiaVancouver

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok